All News #Library
Sciences
Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock
26 Jan 2021 //
PRNEWSWIRE
Lipocine Announces USPTO Declaration Of Interference Between Lipocine
14 Jan 2021 //
PRNEWSWIRE
Lipocine Announces Positive Topline Phase 2 Results from LPCN 11442
12 Jan 2021 //
LIPOCINE
Lipocine Announces Publication of LPCN 1144 Liver Fat Study ("LFS") Results
03 Aug 2020 //
PRNEWSWIRE

Market Place
Sourcing Support